Table 3.
Cutoff values and corresponding sensitivity/specificity.
| AD vs. NAD | AD vs. control | |||
|---|---|---|---|---|
| CV | SE%, SP% | CV | SE%, SP% | |
| Aβ42 (pg/mL) | < 570.9 | 56.6, 84.6 | < 620.8 | 65.0, 90.4 |
| T-Tau (pg/mL) | >241.6 | 81.1, 90.4 | >286.8 | 82.7, 95.0 |
| 181P-Tau (pg/mL) | >56.49 | 88.7, 84.6 | >55.32 | 84.6, 95.0 |
| T-Tau/Aβ42 | >0.5290 | 84.9, 90.4 | >0.4140 | 92.3, 85.0 |
| 181P-tau/ Aβ42 | >0.08465 | 77.4, 90.4 | >0.09536 | 88.5, 95.0 |
| R | >0.4117 | 86.5, 92.4 | >0.2464 | 100, 96.2 |
CV, cutoff value; SE%, SP%, sensitivity%, specificity%; AD, Alzheimer's disease group; NAD, non-Alzheimer's disease group; R, predicting factor from logistic regression.